Teladoc Health Sees Q4 GAAP EPS $(0.25)-$(0.10) vs $(0.17) Est; Sees Sales $622.000M-$652.000M vs $634.855M Est
Author: Benzinga Newsdesk | October 29, 2025 03:10pm
Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.25)-$(0.10) vs $(0.17) analyst estimate. sees sales of $622.000 million-$652.000 million vs $634.855 million analyst estimate.